• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT TOTAL PSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT TOTAL PSA Back to Search Results
Catalog Number 07K70-35
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number (b)(4) that has a similar product distributed in the us, list number (b)(4).
 
Event Description
The customer reported a falsely decreased architect total psa result on one (b)(6) male patient previously diagnosed with prostate cancer.Results provided: 1.5 ng/ml, repeated the same.The patient is monitored every three months.Previous results provided: (b)(6) 2019 = 30.5 ng/ml; (b)(6) 2019 = 23.9 ng/ml; (b)(6) 2019 = 8.5 ng/ml.No impact to patient management was reported.
 
Manufacturer Narrative
A review of complaints for the architect total psa, lot# 01369fn00 assay determined that there are no trends for the product related to patient results.Return testing was not completed as returns were not available.Global data was evaluated and the patient median result for lot 01369fn00 was analyzed and found to be within established baselines and confirms no systemic issues for this lot.A review of the manufacturing documentation did not identify any issues associated with the customers observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect total psa, lot# 01369fn00 assay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL PSA
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key9191353
MDR Text Key194480241
Report Number3008344661-2019-00123
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/15/2019
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/09/2020
Device Catalogue Number07K70-35
Device Lot Number01369FN00
Was Device Available for Evaluation? No
Date Manufacturer Received11/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER LIST 03M74-01; ARCHITECT I2000SR ANALYZER LIST 03M74-01; SERIAL (B)(4); SERIAL (B)(4)
-
-